# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 21-30 of 2723 results.
Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors
Status: Suspended
Last Changed: Jul 31, 2018
First Received: Jan 09, 2018
Disease(s): Ovarian Cancer
Intervention(s): OC-EIEs
Locations: Jinshazhou Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China
Yunnan Cancer Hospital & The Third Affiliated Hospital of Kunming Medical University & Yunnan Cancer Center, Kunming, Yunnan, China
A Study to Evaluate the Effectiveness and Tolerability of a Second Maintenance Treatment in Participants With Ovarian Cancer, Who Have Previously Received Polyadenosine 5'Diphosphoribose [Poly (ADP Ribose)] Polymerase Inhibitor (PARPi) Treatment.
Status: Recruiting
Last Changed: Oct 05, 2020
First Received: Jan 23, 2020
Disease(s): Ovarian Cancer
Intervention(s): Olaparib, Ceralasertib, Placebo to match olaparib
Locations: Research Site, Anchorage, Alaska, United States
Research Site, La Jolla, California, United States
Research Site, Long Beach, California, United States
Research Site, Los Angeles, California, United States
Research Site, West Hollywood, California, United States
... and 37 other locations.
Influence of Chemotherapy on Gamma-delta T Cells in Patients With Epithelial Ovarian Cancer
Status: Withdrawn
Last Changed: Aug 11, 2014
First Received: May 25, 2012
Disease(s): Ovarian Cancer
Intervention(s): Carboplatin and / or taxol chemotherapy
Locations: CHU de RENNES, Rennes, France
Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer
Status: Recruiting
Last Changed: Oct 26, 2020
First Received: Aug 11, 2017
Disease(s): Ovarian Cancer
Intervention(s): Fostamatinib and Paclitaxel
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Palbociclib Plus Letrozole Treatment After Progression to Second Line Chemotherapy for Women With ER/PR-positive Ovarian Cancer.
Status: Recruiting
Last Changed: Jun 16, 2020
First Received: May 03, 2019
Disease(s): Ovarian Cancer
Intervention(s): Palbociclib 125mg, Letrozole 2.5mg
Locations: Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
CPO Pucrs, Porto Alegre, Rio Grande Do Sul, Brazil
Instituto Nacional do Câncer - INCA, Rio De Janeiro, Brazil
AC Camargo Cancer Center, São Paulo, Brazil
Hospital Beneficência Portuguesa, São Paulo, Brazil
... and 3 other locations.
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients.
Status: Recruiting
Last Changed: Oct 08, 2020
First Received: Nov 09, 2018
Disease(s): Advanced Ovarian Cancer
Intervention(s): Bevacizumab, Durvalumab, Olaparib, Placebo olaparib, Durvalumab placebo, Carboplatin+Paclitaxel
Locations: Research Site, Foothill Ranch, California, United States
Research Site, Los Angeles, California, United States
Research Site, Oakland, California, United States
Research Site, Orange, California, United States
Research Site, Roseville, California, United States
... and 210 other locations.
Masitinib in Combination With Gemcitabine in Advanced/Metastatic Epithelial Ovarian Cancer Patients
Status: Active, not recruiting
Last Changed: Apr 06, 2020
First Received: Jul 03, 2015
Disease(s): Ovarian Cancer
Intervention(s): Masitinib, Gemcitabine, Placebo
Locations: Centre hospitalo-universitaire de Beni Messous, Algiers, Algeria
Institut Sainte Catherine, Avignon, France
City Oncology Clinic, St.-Petersburg, Russian Federation
Complejo Hospitalario Universitario de Santiago, Santiago, Spain
Lviv State Oncological Regional Treatment and Diagnostic Center, Lviv, Ukraine
... and 2 other locations.
Clinical Study of Apatinib in the Treatment of Platinum Resistant Recurrent Ovarian Cancer
Status: Terminated
Last Changed: Aug 05, 2020
First Received: Jul 16, 2018
Disease(s): Ovarian Cancer
Intervention(s): Apatinib
Locations: The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China
Cabazitaxel in Platinum Refractory Ovarian Cancer
Status: Terminated
Last Changed: Dec 04, 2014
First Received: Dec 11, 2012
Disease(s): Ovarian Cancer
Intervention(s): Cabazitaxel
Locations: Department of Oncology, Aalborg Hospital, Aalborg, Denmark
Herlev Hospital, Herlev, Denmark
Department of Oncology, Odense University Hospital, Odense, Denmark
Department of Oncology, Vejle Hospital, Vejle, Denmark
Restrictive or Individualized Goal-Directed Fluid Replacement Strategy in Ovarian Cancer Cytoreductive Surgery
Status: Completed
Last Changed: Jan 31, 2020
First Received: May 08, 2018
Disease(s): Ovarian Cancer
Intervention(s): EV1000(FloTrac System 4.0)
Locations: Tata Medical Centre, Kolkata, West Bengal, India